Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$7.03 - $11.07 $42 - $66
6 New
6 $0
Q3 2022

Nov 14, 2022

SELL
$12.16 - $19.42 $3,648 - $5,826
-300 Reduced 50.0%
300 $4,000
Q2 2022

Aug 12, 2022

BUY
$9.99 - $21.35 $2,997 - $6,405
300 Added 100.0%
600 $7,000
Q4 2021

Feb 09, 2022

BUY
$26.55 - $40.57 $7,965 - $12,171
300 New
300 $8,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Sittner & Nelson, LLC Portfolio

Follow Sittner & Nelson, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sittner & Nelson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sittner & Nelson, LLC with notifications on news.